ModernVivo
ModernVivo provides a literature intelligence platform for researchers in drug discovery and development. Its product analyzes millions of peer-reviewed publications to help users identify relevant in vivo models, extract detailed protocol conditions, and cross-reference data with clinical trial and regulatory guidance. The platform aims to accelerate and improve study design for scientists in industry and academia.
Facts
- HQ
- Seattle
- Sectors
- Software Development
- Founded
- 2023
- Type
- Corporation Seattle business license
- Employees
- 6
- Registered name
- ModernVivo Inc Seattle business license
- Stage
- PreSeed
Is this your organization? Claim it
ModernVivo uses AI to analyze millions of animal studies, cutting literature review from weeks to minutes
ModernVivo, a Seattle startup, uses AI to scan millions of published animal studies and related data to help researchers design preclinical drug experiments faster, reducing literature review time from weeks to minutes and aiming to improve experiment quality while using fewer animals.
ModernVivo launches ModernVivo Marketplace on Sept. 15, 2026 to connect preclinical teams with pre-vetted CROs
ModernVivo announced on Sept. 15, 2026 the launch of ModernVivo Marketplace, a service to help preclinical R&D teams find pre-vetted CROs faster for in vivo study design and execution.
Nineteen Startups Graduate from Creative Destruction Lab’s Seattle Accelerator, Raising Over $190 Million Since 2022
Nineteen startups graduated from the Creative Destruction Lab’s nine-month accelerator program in Seattle, hosted at the University of Washington’s Foster School of Business. The cohort includes companies from manufacturing and computational health sectors, and CDL-Seattle startups have collectively raised at least $190 million since 2022.
People
-
Ian Levine Co-Founder and CEO
Online
Questions about ModernVivo
What is ModernVivo?
ModernVivo is a startup based in Seattle that provides a literature intelligence platform for researchers in drug discovery and development. The platform helps researchers identify in vivo models, extract protocol conditions, and cross-reference findings with clinical trial and regulatory guidance.
What is ModernVivo known for?
ModernVivo is known for using AI to analyze animal studies and for ModernVivo Marketplace, which connects preclinical teams with pre-vetted CROs.
What has ModernVivo been in the news for?
GeekWire reported in September 2026 that ModernVivo uses AI to analyze millions of animal studies, cutting literature review from weeks to minutes. Cision PR Newswire reported in September 2026 that ModernVivo was launching ModernVivo Marketplace on September 15, 2026 to connect preclinical teams with pre-vetted CROs.
Who are the people behind ModernVivo?
Ian Levine is ModernVivo’s co-founder and CEO.
Who invested in ModernVivo, and how much has it raised?
Members of Seattle Flow see ModernVivo's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is ModernVivo based?
ModernVivo is based in Seattle.